Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 81

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 6
Chunk 81
---
 period accordingly. The unvested FY21 equity options for Kathryn Andrews were forfeited due to cessation of employment.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(2)   Includes $169,000 corporate advisory fees paid to an associate entity of Mr. Geoffrey Kempler for business advisory services including investor relations, marketing and business development.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(3)   Dr. David Stamler gets paid in US dollars.
------------------------------------------------

Performance income as a proportion of total remuneration

All executives are eligible to receive incentives as determined by the Board from time to time. Their performance payments are based on a set monetary value, set number of shares or options or as a portion of base salary.

Non-Executive Directors are not entitled to receive bonuses and/or incentives. In the current year, the Directors have received equity as part of their total remuneration. Employees have received equity as recommended by the Remuneration Committee.

                                             Fixed remuneration                       STI                          LTI          
--------------------------------------------------------------------------------------------------------------------------------
                                          2025                    2024   2025             2024               2025      2024     
                                             %                       %       %                %                 %          %    
Directors                                                                                                                       
Mr. Geoffrey Kempler                        56                     100       -                -                44          -    
Mr. Brian Meltzer                           46                     100           -                -            54              -
Mr. Peter Marks                             46                     100           -                -            54              -
Mr. Lawrence Gozlan                         34                     100           -                -            66              -
Other key management personnel                                                                                                  
Dr. David Stamler                           59                      49       18               12               23          39   
Ms. Kathryn Andrews                        N/A                     100           N/A              -           N/A              -

Long-term incentive (“LTI”) related to remuneration were provided in the form of share-based payments.

Short-term incentives (“STI”) related to remuneration were provided in the form of cash bonus.

49

c)   Share-based compensation
-----------------------------

We have an Employee and Consultant Plan designed to reward Executives, Employees and/or Consultants for their contributions. Due to our United States presence, a United States plan, and an Australian plan were also developed. At June 30, 2025, equity had been issued to four (4) Directors, one (1) Key Management Personnel, seven (7) employees and three (3) consultants under